DR. ASAD NASIR MD
Prescription History 1346446721
Internal Medicine - Pulmonary Disease in Elmira, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. ASAD NASIR MD, an active Pulmonary Disease specialist practicing in Elmira, NY. Our medical registry currently tracks 36 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 2,406 documented patient claims. Among these therapy options, the most frequently utilized medication is Albuterol Sulfate Hfa, which accounts for 530 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 530 | $35.50 | ▲ More than typical |
About Albuterol Sulfate Hfa: Albuterol (also known as salbutamol) is used to prevent and treat wheezing and shortness of breath caused by breathing problems (such as asthma, chronic obstructive pulmonary disease). Show more ▾ It is also used to prevent asthma brought on by exercise. It is a quick-relief drug. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. In 2024, this provider wrote 530 Medicare prescriptions for Albuterol Sulfate Hfa, about 7.2 times the volume of the typical New York prescriber of this medication (73.9). Medicare paid an average of $35.50 per fill, versus $33.48 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 645.9 30-Day Fills standardized to 30-day supplies 15,664 Days of Medication total across all patients in 2024 | |||
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 314 | $941.38 | ▲ More than typical |
About Trelegy Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 3 medications: fluticasone, umeclidinium, and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling of the airways in the lungs to make breathing easier. Umeclidinium belongs to a class of drugs known as anticholinergics and vilanterol is a LABA medication. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Both drugs are also known as bronchodilators. When used alone, long-acting beta agonists (such as vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination products containing both an inhaled corticosteroid and long-acting beta agonist, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with two asthma-control medications (such as inhaled corticosteroid and long-acting beta agonist) or if your symptoms need combination treatment. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. In 2024, this provider wrote 314 Medicare prescriptions for Trelegy Ellipta, about 5.1 times the volume of the typical New York prescriber of this medication (61.1). Medicare paid an average of $941.38 per fill, versus $832.82 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 476 30-Day Fills standardized to 30-day supplies 14,280 Days of Medication total across all patients in 2024 | |||
| Breo ElliptaFluticasone/Vilanterol | 197 | $499.35▼ below NY avg | ▲ More than typical |
About Breo Ellipta: This medication is used to prevent and decrease symptoms (wheezing and trouble breathing) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). Show more ▾ This inhaler contains 2 medications: fluticasone and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. Vilanterol belongs to a class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. When used alone, long-acting beta agonists (like vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2024, this provider wrote 197 Medicare prescriptions for Breo Ellipta, about 5.2 times the volume of the typical New York prescriber of this medication (37.5). Medicare paid an average of $499.35 per fill, versus $511.52 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 257 30-Day Fills standardized to 30-day supplies 7,710 Days of Medication total across all patients in 2024 | |||
| Azithromycin | 138 | $9.85 | ▲ More than typical |
About Azithromycin: Azithromycin is used to treat a wide variety of bacterial infections. Show more ▾ It is a macrolide-type antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. In 2024, this provider wrote 138 Medicare prescriptions for Azithromycin, about 3.6 times the volume of the typical New York prescriber of this medication (38.3). Medicare paid an average of $9.85 per fill, versus $4.76 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 260.2 30-Day Fills standardized to 30-day supplies 7,143 Days of Medication total across all patients in 2024 | |||
| Prednisone | 119 | $5.94 | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 119 Medicare prescriptions for Prednisone, about 2.6 times the volume of the typical New York prescriber of this medication (46.6). Medicare paid an average of $5.94 per fill, versus $4.12 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 155.5 30-Day Fills standardized to 30-day supplies 3,319 Days of Medication total across all patients in 2024 | |||
| Spiriva RespimatTiotropium Bromide | 106 | $803.52 | ▲ More than typical |
About Spiriva Respimat: Tiotropium is used to treat lung diseases such as asthma and COPD (bronchitis, emphysema). Show more ▾ It must be used regularly to prevent wheezing and shortness of breath. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 106 Medicare prescriptions for Spiriva Respimat, about 3.5 times the volume of the typical New York prescriber of this medication (30.6). Medicare paid an average of $803.52 per fill, versus $690.92 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 164 30-Day Fills standardized to 30-day supplies 4,920 Days of Medication total across all patients in 2024 | |||
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 94 | $712.80▼ below NY avg | ▲ More than typical |
About Breztri Aerosphere: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you maintain your normal activities and decreases time lost from work or school. This inhaler contains 3 medications: budesonide, glycopyrrolate, and formoterol. Budesonide works by reducing the irritation and swelling of the airways. Budesonide belongs to a class of drugs known as corticosteroids. Glycopyrrolate and formoterol work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Glycopyrrolate belongs to a class of drugs known as anticholinergics. Formoterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This medication is not approved to treat asthma. In 2024, this provider wrote 94 Medicare prescriptions for Breztri Aerosphere, about 2.1 times the volume of the typical New York prescriber of this medication (45.1). Medicare paid an average of $712.80 per fill, versus $778.51 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 110 30-Day Fills standardized to 30-day supplies 3,290 Days of Medication total across all patients in 2024 | |||
| Incruse ElliptaUmeclidinium Bromide | 85 | $394.42▼ below NY avg | ▲ More than typical |
About Incruse Ellipta: Umeclidinium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). Show more ▾ It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. Muscarinic Antagonist. In 2024, this provider wrote 85 Medicare prescriptions for Incruse Ellipta, about 2.9 times the volume of the typical New York prescriber of this medication (29.5). Medicare paid an average of $394.42 per fill, versus $425.32 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 101 30-Day Fills standardized to 30-day supplies 3,030 Days of Medication total across all patients in 2024 | |||
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 73 | $220.89 | ▲ More than typical |
About Budesonide-Formoterol Fumarate: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. In 2024, this provider wrote 73 Medicare prescriptions for Budesonide-Formoterol Fumarate, about 3 times the volume of the typical New York prescriber of this medication (24.3). Medicare paid an average of $220.89 per fill, versus $213.59 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 102 30-Day Fills standardized to 30-day supplies 3,060 Days of Medication total across all patients in 2024 | |||
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 69 | $592.67 | ▲ More than typical |
About Anoro Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: umeclidinium and vilanterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Vilanterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Umeclidinium/vilanterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as vilanterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems. In 2024, this provider wrote 69 Medicare prescriptions for Anoro Ellipta, about 2 times the volume of the typical New York prescriber of this medication (34.4). Medicare paid an average of $592.67 per fill, versus $589.77 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 95 30-Day Fills standardized to 30-day supplies 2,850 Days of Medication total across all patients in 2024 | |||
| Montelukast Sodium | 66 | $7.88▼ below NY avg | ≈ Typical |
About Montelukast Sodium: Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). Show more ▾ It is also used before exercise to prevent breathing problems during exercise (bronchospasm). This medication can help decrease the number of times you need to use your quick relief inhaler. Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose). Since there are other allergy medications that may be safer (see also Warning section), this medication should be used for this condition only when you cannot take other allergy medications or they do not work well. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This drug works by blocking certain natural substances (leukotrienes) that may cause or worsen asthma and allergies. It helps make breathing easier by reducing swelling (inflammation) in the airways. A leukotriene D4 receptor antagonist. In 2024, this provider wrote 66 Medicare prescriptions for Montelukast Sodium, about 1.2 times the volume of the typical New York prescriber of this medication (57.2). Medicare paid an average of $7.88 per fill, versus $9.83 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 168.9 30-Day Fills standardized to 30-day supplies 5,066 Days of Medication total across all patients in 2024 | |||
| SymbicortBudesonide/Formoterol Fumarate | 58 | $311.21 | ▲ More than typical |
About Symbicort: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 58 Medicare prescriptions for Symbicort, about 2.2 times the volume of the typical New York prescriber of this medication (26.5). Medicare paid an average of $311.21 per fill, versus $292.92 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 87 30-Day Fills standardized to 30-day supplies 2,610 Days of Medication total across all patients in 2024 | |||
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 52 | $185.39 | ▲ More than typical |
About Fluticasone-Salmeterol: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 52 Medicare prescriptions for Fluticasone-Salmeterol, about 1.7 times the volume of the typical New York prescriber of this medication (29.9). Medicare paid an average of $185.39 per fill, versus $155.70 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 80 30-Day Fills standardized to 30-day supplies 2,400 Days of Medication total across all patients in 2024 | |||
| Ventolin HfaAlbuterol Sulfate | 51 | $63.38▼ below NY avg | ▲ More than typical |
About Ventolin Hfa: Albuterol (also known as salbutamol) is used to prevent and treat wheezing and shortness of breath caused by breathing problems (such as asthma, chronic obstructive pulmonary disease). Show more ▾ It is also used to prevent asthma brought on by exercise. It is a quick-relief drug. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. In 2024, this provider wrote 51 Medicare prescriptions for Ventolin Hfa, about 2 times the volume of the typical New York prescriber of this medication (25.5). Medicare paid an average of $63.38 per fill, versus $67.34 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 54.2 30-Day Fills standardized to 30-day supplies 1,355 Days of Medication total across all patients in 2024 | |||
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 33 | $8.54▼ below NY avg | ≈ Typical |
About Amoxicillin-Clavulanate Potass: Amoxicillin/clavulanic acid is a combination penicillin-type antibiotic used to treat a wide variety of bacterial infections. Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2024, this provider wrote 33 Medicare prescriptions for Amoxicillin-Clavulanate Potass, about 1.2 times the volume of the typical New York prescriber of this medication (27.8). Medicare paid an average of $8.54 per fill, versus $8.73 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 33 30-Day Fills standardized to 30-day supplies 288 Days of Medication total across all patients in 2024 | |||
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 31 | $758.58 | ≈ Typical |
About Stiolto Respimat: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: tiotropium and olodaterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Olodaterol belongs to the class of drugs known as long-acting inhaled beta-agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Tiotropium/olodaterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as olodaterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems. In 2024, this provider wrote 31 Medicare prescriptions for Stiolto Respimat, about the same volume as the typical New York prescriber of this medication (32.8). Medicare paid an average of $758.58 per fill, versus $635.51 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 49 30-Day Fills standardized to 30-day supplies 1,470 Days of Medication total across all patients in 2024 | |||
| Tiotropium Bromide | 29 | $318.69▼ below NY avg | ▲ More than typical |
About Tiotropium Bromide: Tiotropium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis and emphysema). Show more ▾ It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 29 Medicare prescriptions for Tiotropium Bromide, about 1.8 times the volume of the typical New York prescriber of this medication (16.4). Medicare paid an average of $318.69 per fill, versus $493.96 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 29 30-Day Fills standardized to 30-day supplies 870 Days of Medication total across all patients in 2024 | |||
| BreynaBudesonide/Formoterol Fumarate | 28 | $183.86▼ below NY avg | ▲ More than typical |
About Breyna: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. In 2024, this provider wrote 28 Medicare prescriptions for Breyna, about 1.4 times the volume of the typical New York prescriber of this medication (19.8). Medicare paid an average of $183.86 per fill, versus $222.90 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 30 30-Day Fills standardized to 30-day supplies 900 Days of Medication total across all patients in 2024 | |||
| Levofloxacin | 27 | $2.87▼ below NY avg | ≈ Typical |
About Levofloxacin: Levofloxacin is used to treat a variety of bacterial infections. Show more ▾ This medication belongs to a class of drugs known as quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. The L-isomer of Ofloxacin. In 2024, this provider wrote 27 Medicare prescriptions for Levofloxacin, about the same volume as the typical New York prescriber of this medication (26.2). Medicare paid an average of $2.87 per fill, versus $5.47 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 27 30-Day Fills standardized to 30-day supplies 263 Days of Medication total across all patients in 2024 | |||
| Arnuity ElliptaFluticasone Furoate | 26 | $257.34▼ below NY avg | ≈ Typical |
About Arnuity Ellipta: Fluticasone is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Show more ▾ Controlling symptoms of asthma helps you maintain your normal activities and decreases time lost from work or school. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) of the airways in the lungs to make breathing easier. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS. In 2024, this provider wrote 26 Medicare prescriptions for Arnuity Ellipta, about the same volume as the typical New York prescriber of this medication (27.7). Medicare paid an average of $257.34 per fill, versus $287.31 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 34 30-Day Fills standardized to 30-day supplies 1,020 Days of Medication total across all patients in 2024 | |||
| NucalaMepolizumab | 25 | $3,856.35▼ below NY avg | ≈ Typical |
About Nucala: This medication is used along with other medications to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Show more ▾ Controlling symptoms of asthma helps you do your normal activities and decreases time lost from work or school. Mepolizumab is also used to treat certain other immune system disorders (chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome). This medication works by decreasing a certain type of white blood cell (eosinophils). This effect helps reduce swelling (inflammation) of the airways to make breathing easier. It may also help reduce the size of nasal polyps, and lessen symptoms such as runny/stuffy nose, mucus in the throat, loss of smell, facial pain, and tiredness. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack occurs, use your quick-relief inhaler as prescribed. A humanized monoclonal antibody to IL-5 in cynomolgus monkeys. In 2024, this provider wrote 25 Medicare prescriptions for Nucala, about the same volume as the typical New York prescriber of this medication (24.7). Medicare paid an average of $3,856.35 per fill, versus $4,428.45 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 26.8 30-Day Fills standardized to 30-day supplies 756 Days of Medication total across all patients in 2024 | |||
| DuleraMometasone/Formoterol | 25 | $476.47 | ≈ Typical |
About Dulera: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. Show more ▾ It contains 2 medications: mometasone and formoterol. Mometasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. A pharmaceutical preparation of mometasone furoate and formoterol fumarate that is used as an inhaled dosage form for the treatment of ASTHMA. In 2024, this provider wrote 25 Medicare prescriptions for Dulera, about 1.2 times the volume of the typical New York prescriber of this medication (21.1). Medicare paid an average of $476.47 per fill, versus $417.59 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 37 30-Day Fills standardized to 30-day supplies 1,110 Days of Medication total across all patients in 2024 | |||
| Advair HfaFluticasone Propion/Salmeterol | 23 | $337.06▼ below NY avg | ≈ Typical |
About Advair Hfa: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. Show more ▾ It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. This product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your asthma symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 23 Medicare prescriptions for Advair Hfa, about the same volume as the typical New York prescriber of this medication (22.3). Medicare paid an average of $337.06 per fill, versus $430.15 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 27 30-Day Fills standardized to 30-day supplies 810 Days of Medication total across all patients in 2024 | |||
| Furosemide | 23 | $1.51▼ below NY avg | ▼ Less than typical |
About Furosemide: Furosemide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. Show more ▾ This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. This drug is also used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Furosemide is a "water pill" (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt. A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. In 2024, this provider wrote 23 Medicare prescriptions for Furosemide, about a third of the volume of the typical New York prescriber of this medication (69.7). Medicare paid an average of $1.51 per fill, versus $4.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 54.5 30-Day Fills standardized to 30-day supplies 1,603 Days of Medication total across all patients in 2024 | |||
| Combivent RespimatIpratropium/Albuterol Sulfate | 20 | $853.92 | ≈ Typical |
About Combivent Respimat: This product is used to treat and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). Show more ▾ This product contains 2 medications: ipratropium and albuterol (also known as salbutamol). Both drugs work by relaxing the muscles around the airways so that the airways open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A combined pharmaceutical preparation of Ipratropium Bromide and Albuterol Sulfate that is used to treat the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 20 Medicare prescriptions for Combivent Respimat, about 86% of the volume of the typical New York prescriber of this medication (23.2). Medicare paid an average of $853.92 per fill, versus $586.79 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 38 30-Day Fills standardized to 30-day supplies 1,110 Days of Medication total across all patients in 2024 | |||
| Fluticasone Propionate | 20 | $12.32▼ below NY avg | ▼ Less than typical |
About Fluticasone Propionate: Fluticasone is used to relieve seasonal and year-round allergic and non-allergic nasal symptoms, such as stuffy/runny nose, itching, and sneezing. Show more ▾ It can also help relieve allergy eye symptoms such as itchy, watery eyes. This medication belongs to a class of drugs known as corticosteroids. It works in your nose to block the effects of substances that cause allergies (such as pollen, pet dander, dust mites, mold) and to reduce swelling. A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS. In 2024, this provider wrote 20 Medicare prescriptions for Fluticasone Propionate, about a third of the volume of the typical New York prescriber of this medication (62.3). Medicare paid an average of $12.32 per fill, versus $12.76 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 35 30-Day Fills standardized to 30-day supplies 1,050 Days of Medication total across all patients in 2024 | |||
| Spironolactone | 19 | $9.91 | ▼ Less than typical |
About Spironolactone: Spironolactone is used to treat high blood pressure and heart failure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat swelling (edema) caused by certain conditions (such as heart failure, liver disease) by removing excess fluid and improving symptoms such as breathing problems. This medication is also used to treat conditions in which the body is making too much of a natural substance (aldosterone). Spironolactone is known as a "water pill" (potassium-sparing diuretic). A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827) In 2024, this provider wrote 19 Medicare prescriptions for Spironolactone, about half the volume of the typical New York prescriber of this medication (41.6). Medicare paid an average of $9.91 per fill, versus $8.37 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2024 | |||
| Levalbuterol Tartrate HfaLevalbuterol Tartrate | 18 | $77.04 | ≈ Typical |
About Levalbuterol Tartrate Hfa: Levalbuterol is used to prevent and treat wheezing and shortness of breath caused by breathing problems (such as asthma, chronic obstructive pulmonary disease). Show more ▾ It is a quick-relief drug. Levalbuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. This drug is not approved for use in children younger than 4 years due to increased risk of side effects (such as unusual fast breathing, worsening asthma). Ask your doctor or pharmacist for details. The R-isomer of albuterol. In 2024, this provider wrote 18 Medicare prescriptions for Levalbuterol Tartrate Hfa, about 82% of the volume of the typical New York prescriber of this medication (22). Medicare paid an average of $77.04 per fill, versus $65.81 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 33.1 30-Day Fills standardized to 30-day supplies 992 Days of Medication total across all patients in 2024 | |||
| Theophylline ErTheophylline Anhydrous | 16 | $256.66 | ▼ Less than typical |
About Theophylline Er: Theophylline is used to treat lung diseases such as asthma and COPD (bronchitis, emphysema). Show more ▾ It must be used regularly to prevent wheezing and shortness of breath. This medication belongs to a class of drugs known as xanthines. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. It also decreases the lungs' response to irritants. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP. In 2024, this provider wrote 16 Medicare prescriptions for Theophylline Er, about half the volume of the typical New York prescriber of this medication (32.9). Medicare paid an average of $256.66 per fill, versus $74.81 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 40.1 30-Day Fills standardized to 30-day supplies 1,202 Days of Medication total across all patients in 2024 | |||
| TezspireTezepelumab-Ekko | 14 | $4,143.24▼ below NY avg | ▼ Less than typical |
About Tezspire: This medication is used with other medications to control and prevent symptoms of severe asthma (such as wheezing and shortness of breath). Show more ▾ Controlling symptoms of asthma helps you maintain your normal activities and decreases time lost from work or school. Tezepelumab belongs to a class of medications known as monoclonal antibodies. It helps reduce swelling (inflammation) of the airways in the lungs to make breathing easier. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack occurs, use your quick-relief inhaler as prescribed. Targets epithelial-cell-derived cytokine thymic stromal lymphopoietin for treatment of asthma. In 2024, this provider wrote 14 Medicare prescriptions for Tezspire, about 61% of the volume of the typical New York prescriber of this medication (22.9). Medicare paid an average of $4,143.24 per fill, versus $4,476.46 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 14 30-Day Fills standardized to 30-day supplies 392 Days of Medication total across all patients in 2024 | |||
| Wixela InhubFluticasone Propion/Salmeterol | 14 | $267.53 | ▼ Less than typical |
About Wixela Inhub: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2024, this provider wrote 14 Medicare prescriptions for Wixela Inhub, about 64% of the volume of the typical New York prescriber of this medication (21.8). Medicare paid an average of $267.53 per fill, versus $149.61 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2024 | |||
| OfevNintedanib Esylate | 13 | $12,821.02▼ below NY avg | ▼ Less than typical |
About Ofev: This medication is used to treat certain types of lung disease (idiopathic pulmonary fibrosis- IPF, interstitial lung disease). Show more ▾ Both types of lung disease scar and stiffen your lungs, making it hard to breathe. Nintedanib may help slow down the worsening of your lung disease. In 2024, this provider wrote 13 Medicare prescriptions for Ofev, about a third of the volume of the typical New York prescriber of this medication (33.6). Medicare paid an average of $12,821.02 per fill, versus $13,129.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 13 | $13.66 | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 13 Medicare prescriptions for Gabapentin, about 16% of the volume of the typical New York prescriber of this medication (82.1). Medicare paid an average of $13.66 per fill, versus $12.77 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2024 | |||
| Doxycycline Hyclate | 13 | $4.66▼ below NY avg | ▼ Less than typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 13 Medicare prescriptions for Doxycycline Hyclate, about half the volume of the typical New York prescriber of this medication (30.4). Medicare paid an average of $4.66 per fill, versus $11.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 13 30-Day Fills standardized to 30-day supplies 97 Days of Medication total across all patients in 2024 | |||
| Roflumilast | 12 | $39.83▼ below NY avg | ▼ Less than typical |
About Roflumilast: Roflumilast is used to control and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis). Show more ▾ It should be used along with other medications (bronchodilators such as salmeterol, ipratropium) to treat COPD. It works by reducing the irritation and swelling of the airways. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath or wheezing. If sudden breathing problems occur, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2024, this provider wrote 12 Medicare prescriptions for Roflumilast, about a third of the volume of the typical New York prescriber of this medication (31.4). Medicare paid an average of $39.83 per fill, versus $99.36 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 16 30-Day Fills standardized to 30-day supplies 480 Days of Medication total across all patients in 2024 | |||
| Mometasone Furoate | 12 | $77.17 | ▼ Less than typical |
About Mometasone Furoate: This medication is used to treat skin conditions such as eczema, psoriasis, allergies, and rash. Show more ▾ Mometasone decreases swelling (inflammation), itching, and redness. Mometasone is a medium-strength corticosteroid. This medication is available in several forms including cream, ointment, and lotion (solution). Your doctor will choose the type of product based on the skin condition/area of the body being treated. A pregnadienediol derivative ANTI-ALLERGIC AGENT and ANTI-INFLAMMATORY AGENT that is used in the management of ASTHMA and ALLERGIC RHINITIS. It is also used as a topical treatment for skin disorders. In 2024, this provider wrote 12 Medicare prescriptions for Mometasone Furoate, about a quarter of the volume of the typical New York prescriber of this medication (43.8). Medicare paid an average of $77.17 per fill, versus $40.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. ASAD NASIR MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Pulmonary Disease prescribing approach at this Elmira, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NY prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
